-
2024-515574-27-00
Down Syndrome 4 2024-07-03
-
2024-514967-25-00
Cancer 4 2024-07-03
-
2023-510508-31-01
cognitive impairment 4 2024-07-01
-
2024-513596-40-00
Pleural empyema 6 2024-06-28
-
2023-507111-35-00
Prostate Cancer 9 2024-06-03
-
2024-512491-35-00
cronic kidney disease 4 2024-04-01
-
2022-503036-13-00
Head and neck squamous cell carcinoma, thyroid carcinom 4 2024-02-01
-
2023-506508-18-00
Parkinson's disease 10 2024-01-19
-
2024-517095-38-00
multiple myeloma 10 2023-12-18
-
2023-503985-21-00
Non small cell lung cancer 3 2023-11-07
-
2024-511659-17-00
Solid tumors 4 2023-05-01
-
2024-513843-10-00
neuroblastoma 9 2023-02-28
-
2024-517851-11-00
Investigation in healthy volunteers and Alzheimer's dis 1 2022-09-05
-
2024-516083-28-00
Prostate cancer 10 2022-06-01
-
2024-514785-39-00
Gastroenteropancreatic neuroendocrine tumours (GEP-NETs 4 2021-09-24
-
2024-517048-67-00
Cerebral commotio 4 2021-04-21
-
2024-515895-11-00
histiocytic cell proliferation 6 2021-04-15
-
2024-518721-15-00
Apathy 5 2021-04-13
-
2024-515408-37-00
glioblastoma multiforme 4 2020-04-01
-
2024-515414-40-00
Heart failure 9 2019-12-01
-
2024-517074-17-00
Alzheimer's disease 10 2019-05-20
-
2024-511842-38-00
Neurodegenerative disorders with Tau-pathology; includi 4 2017-04-10
-
2024-514108-15-01
Allergies 4 2025-04-11
-
2023-508824-36-00
Diabetic Kidney Disease 4 2024-09-24